During the past decade, Gemeinschaftspraxis Mohm / Prange-Krex conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gemeinschaftspraxis Mohm / Prange-Krex" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Universität des Saarlandes" with 2 trials sponsored, "Christian Buske" with 1 trials sponsored, "Dr. med. Lars-Olof Muegge" with 1 trials sponsored and "German CLL Study Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gemeinschaftspraxis Mohm / Prange-Krex" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Gemeinschaftspraxis Mohm / Prange-Krex" are "Non-Hodgkin's Lymphoma" (3 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Chronic Lymphoid Leukemia" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Gemeinschaftspraxis Mohm / Prange-Krex" in a lesser frequency.

Most popular intervention types in "Gemeinschaftspraxis Mohm / Prange-Krex" are "Drug" (9 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Bendamustine" (2 trials), "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gemeinschaftspraxis Mohm / Prange-Krex" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Gemeinschaftspraxis Mohm / Prange-Krex". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Gemeinschaftspraxis Mohm / Prange-Krex, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gemeinschaftspraxis Mohm / Prange-Krex, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".